The role of reactive oxygen species in microvascular remodeling

International Journal of Molecular Sciences

Volumn 15, Issue 12, 2014, Pages 23792-23835

  Staiculescu, Marius C ^a   Foote, Christopher ^a   Meininger, Gerald A ^a   Martinez Lemus, Luis A ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Hypertension; Inward remodeling; Microcirculation; Mitochondria; NADPH oxidase; Nox; Resistance arteries; Superoxide; Xanthine oxidase

Indexed keywords

ANGIOTENSIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE; XANTHINE OXIDASE;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ANGIOGENESIS; APOPTOSIS; CELL PROLIFERATION; ENZYME ACTIVITY; HUMAN; HYPERTENSION; MICROCIRCULATION; MICROVASCULAR REMODELING; MITOCHONDRIAL ENERGY TRANSFER; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SHEAR STRESS; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; ANIMAL; METABOLISM; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; SMOOTH MUSCLE FIBER;

ANIMALS; HUMANS; MICROCIRCULATION; MICROVESSELS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; REACTIVE OXYGEN SPECIES;

EID: 84919799117     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151223792     Document Type: Review

References (301)

1. Gu, Y.; Dee, C.M.; Shen, J. Interaction of free radicals, matrix metalloproteinases and caveolin-1 impacts blood-brain barrier permeability. Front. Biosci. Schol. Ed. 2011, 3, 1216-1231.
2. Li, H.; Horke, S.; Forstermann, U. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis 2014, 237, 208-219.
3. Li, H.; Horke, S.; Forstermann, U. Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol. Sci. 2013, 34, 313-319.
4. Montezano, A.C.; Touyz, R.M. Reactive oxygen species, vascular Noxs, and hypertension: Focus on translational and clinical research. Antioxid. Redox Signal. 2014, 20, 164-182.
5. Rubattu, S.; Mennuni, S.; Testa, M.; Mennuni, M.; Pierelli, G.; Pagliaro, B.; Gabriele, E.; Coluccia, R.; Autore, C.; Volpe, M. Pathogenesis of chronic cardiorenal syndrome: Is there a role for oxidative stress? Int. J. Mol. Sci. 2013, 14, 23011-23032.
6. Rochette, L.; Zeller, M.; Cottin, Y.; Vergely, C. Diabetes, oxidative stress and therapeutic strategies. Biochim. Biophys. Acta 2014, 1840, 2709-2729.
7. Hafstad, A.D.; Nabeebaccus, A.A.; Shah, A.M. Novel aspects of ROS signalling in heart failure. Basic Res. Cardiol. 2013, 108, 359, dio:10.1007/s00395-013-0359-8.
8. Satoh, K.; Nigro, P.; Berk, B.C. Oxidative stress and vascular smooth muscle cell growth: A mechanistic linkage by cyclophilin A. Antioxid. Redox Signal. 2010, 12, 675-682.
9. Brandes, R.P.; Weissmann, N.; Schroder, K. Nox family NADPH oxidases in mechano-transduction: Mechanisms and consequences. Antioxid. Redox Signal. 2014, 20, 887-898.
10. San Martin, A.; Griendling, K.K. Redox control of vascular smooth muscle migration. Antioxid. Redox Signal. 2010, 12, 625-640.
11. Mulvany, M.J.; Aalkjaer, C. Structure and function of small arteries. Physiol. Rev. 1990, 70, 921-961.
12. Martinez-Lemus, L.A. The dynamic structure of arterioles. Basic. Clin. Pharmacol. Toxicol. 2012, 110, 5-11.
13. Martinez-Lemus, L.A.; Hill, M.A.; Meininger, G.A., The plastic nature of the vascular wall: A continuum of remodeling events contributing to control of arteriolar diameter and structure. Physiology (Bethesda) 2009, 24, 45-57.
14. Mulvany, M.J.; Baumbach, G.L.; Aalkjaer, C.; Heagerty, A.M.; Korsgaard, N.; Schiffrin, E.L.; Heistad, D.D. Vascular remodeling. Hypertension 1996, 28, 505-506.
15. Staiculescu, M.C.; Galinanes, E.L.; Zhao, G.; Ulloa, U.; Jin, M.; Beig, M.I.; Meininger, G.A.; Martinez-Lemus, L.A. Prolonged vasoconstriction of resistance arteries involves vascular smooth muscle actin polymerization leading to inward remodelling. Cardiovasc. Res. 2013, 98, 428-436.
16. Centers for Disease Control and Prevention (CDC). Vital signs: Prevalence, treatment, and control of hypertension—United States, 1999-2002 and 2005-2008. MMWR Morb. Mortal. Wkly Rep. 2011, 60, 103-108.
17. Feihl, F.; Liaudet, L.; Levy, B.I.; Waeber, B. Hypertension and microvascular remodelling. Cardiovasc. Res. 2008, 78, 274-285.
18. Agabiti-Rosei, E.; Heagerty, A.M.; Rizzoni, D. Effects of antihypertensive treatment on small artery remodelling. J. Hypertens. 2009, 27, 1107-1114.
19. Dupuis, F.; Vincent, J.M.; Limiñana, P.; Chillon, J.M.; Capdeville-Atkinson, C.; Atkinson, J. Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat. J. Hypertens. 2010, 28, 1566-1573.
20. Hassona, M.D. H.; Abouelnaga, Z.A.; Elnakish, M.T.; Awad, M.M.; Alhaj, M.; Goldschmidt-Clermont, P.J.; Hassanain, H.H. Vascular hypertrophy-associated hypertension of profilin1 transgenic mouse model leads to functional remodeling of peripheral arteries. Am. J. Physiol. Heart Circ. Physiol. 2010, 298, H2112-H2120.
21. Izzard, A.S.; Horton, S.; Heerkens, E.H.; Shaw, L.; Heagerty, A.M. Middle cerebral artery structure and distensibility during developing and established phases of hypertension in the spontaneously hypertensive rat. J. Hypertens. 2006, 24, 875-880.
22. Louis, H.; Kakou, A.; Regnault, V.; Labat, C.; Bressenot, A.; Gao-Li, J.; Gardner, H.; Thornton, S.N.; Challande, P.; Li, Z.; Lacolley, P. Role of α 1β 1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H2597-H2604.
23. Ong, S.S.; Baker, P.N.; Mayhew, T.M.; Dunn, W.R. Remodeling of myometrial radial arteries in preeclampsia. Am. J. Obstet. Gynecol. 2005, 192, 572-579.
24. Rizzoni, D.; Porteri, E.; de Ciuceis, C.; Rodella, L.F.; Paiardi, S.; Rizzardi, N.; Platto, C.; Boari, G.E.M.; Pilu, A.; Tiberio, G.A.M., et al. Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome. J. Clin. Endocrinol. Metab. 2009, 94, 5010-5018.
25. Rizzoni, D.; Porteri, E.; Giustina, A.; de Ciuceis, C.; Sleiman, I.; Boari, G.E.; Castellano, M.; Muiesan, M.L.; Bonadonna, S.; Burattin, A., et al. Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. Hypertension 2004, 43, 561-565.
26. Rizzoni, D.; Rossi, G.P.; Porteri, E.; Sticchi, D.; Rodella, L.; Rezzani, R.; Sleiman, I.; de Ciuceis, C.; Paiardi, S.; Bianchi, R., et al. Bradykinin and matrix metalloproteinases are involved the structural alterations of rat small resistance arteries with inhibition of ACE and NEP. J. Hypertens. 2004, 22, 759-766.
27. Rizzoni, D.; Porteri, E.; Guefi, D.; Piccoli, A.; Castellano, M.; Pasini, G.; Muiesan, M.L.; Mulvany, M.J.; Rosei, E.A. Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension 2000, 35, 931-935.
28. Mulvany, M.J. Small artery remodelling in hypertension. Basic Clin. Pharmacol. Toxicol. 2012, 110, 49-55.
29. Heagerty, A.M.; Aalkjaer, C.; Bund, S.J.; Korsgaard, N.; Mulvany, M.J. Small artery structure in hypertension: Dual processes of remodeling and growth. Hypertension 1993, 21, 391-397.
30. Heagerty, A.M.; Heerkens, E.H.; Izzard, A.S. Small artery structure and function in hypertension. J. Cell. Mol. Med. 2010, 14, 1037-1043.
31. Rizzoni, D.; Porteri, E.; Castellano, M.; Bettoni, G.; Muiesan, M.L.; Muiesan, P.; Giulini, S.M.; Agabiti-Rosei, E. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996, 28, 785-690.
32. Beyer, A.M.; Baumbach, G.L.; Halabi, C.M.; Modrick, M.L.; Lynch, C.M.; Gerhold, T.D.; Ghoneim, S.M.; de Lange, W.J.; Keen, H.L.; Tsai, Y.S., et al. Interference with PPARγ signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. Hypertension 2008, 51, 867-871.
33. Rizzoni, D.; Porteri, E.; Guelfi, D.; Muiesan, M.L.; Valentini, U.; Cimino, A.; Girelli, A.; Rodella, L.; Bianchi, R.; Sleiman, I., et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation 2001, 103, 1238-1244.
34. Rizzoni, D.; Agabiti Rosei, E. Small artery remodeling in hypertension and diabetes. Curr. Hypertens. Rep. 2006, 8, 90-5.
35. Vessières, E.; Freidja, M.L.; Loufrani, L.; Fassot, C.; Henrion, D. Flow (shear stress)-mediated remodeling of resistance arteries in diabetes. Vascul. Pharmacol. 2012, 57, 173-178.
36. Amaral, S.L.; Michelini, L.C. Effect of gender on training-induced vascular remodeling in SHR. Braz. J. Med. Biol. Res. 2011, 44, 814-826.
37. Cipolla, M.J.; Sweet, J.G.; Chan, S.L. Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J. Appl. Physiol. 2011, 110, 329-339.
38. Hale, S.A.; Weger, L.; Mandala, M.; Osol, G. Reduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin deposition. Am. J. Physiol. Heart Circ. Physiol. 2011, 301, H1266-H1275.
39. Tarhouni, K.; Guihot, A.L.; Freidja, M.L.; Toutain, B.; Henrion, B.; Baufreton, C.; Pinaud, F.; Procaccio, V.; Grimaud, L.; Ayer, A., et al. Key role of estrogens and endothelial estrogen receptor α in blood flow-mediated remodeling of resistance arteries. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 605-611.
40. Sonoyama, K.; Greenstein, A.; Price, A.; Khavandi, K.; Heagerty, T. Vascular remodeling: Implications for small artery function and target organ damage. Ther. Adv. Cardiovasc. Dis. 2007, 1, 129-137.
41. Hill, M.A.; Meininger, G.A.; Davis, M.J.; Laher, I. Therapeutic potential of pharmacologically targeting arteriolar myogenic tone. Trends Pharmacol. Sci. 2009, 30, 363-374.
42. Heerkens, E.H. J.; Izzard, A.S.; Heagerty, A.M. Integrins, vascular remodeling, and hypertension. Hypertension 2007, 49, 1-4.
43. Tuna, B.G.; Schoorl, M.J.; Bakker, E.N.; de Vos, J.; VanBavel, E. Smooth muscle contractile plasticity in rat mesenteric small arteries: Sensitivity to specific vasoconstrictors, distension and inflammatory cytokines. J. Vasc. Res. 2013, 50, 249-262.
44. Martinez-Lemus, L.A.; Galinanes, E.L. Matrix metalloproteinases and small artery remodeling. Drug Discov. Today Dis. Models 2011, 8, 21-28.
45. Nauseef, W.M. Biological roles for the NOX family NADPH oxidases. J. Biol. Chem. 2008, 283, 16961-16965.
46. Suh, Y.A.; Arnold, R.S.; Lassegue, B.; Shi, J.; Xu, X.; Sorescu, D.; Chung, A.B.; Griendling, K.K.; Lambeth, J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999, 401, 79-82.
47. Banfi, B.; Malgrange, B.; Knisz, J.; Steger, K.; Dubois-Dauphin, M.; Krause, K.H. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J. Biol. Chem. 2004, 279, 46065-46072.
48. Cave, A.C.; Brewer, A.C.; Narayanapanicker, A.; Ray, R.; Grieve, D.J.; Walker, S.; Shah, A.M. NADPH oxidases in cardiovascular health and disease. Antioxid. Redox Signal. 2006, 8, 691-728.
49. Cheng, G.; Cao, Z.; Xu, X.; van Meir, E.G.; Lambeth, J.D. Homologs of gp91phox: Cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 2001, 269, 131-140.
50. Fischer, H. Mechanisms and function of DUOX in epithelia of the lung. Antioxid. Redox Signal. 2009, 11, 2453-2465.
51. Krause, K.H. Tissue distribution and putative physiological function of NOX family NADPH oxidases. Jpn. J. Infect. Dis. 2004, 57, S28-S29.
52. Lassègue, B.; Griendling, K.K. NADPH Oxidases: Functions and Pathologies in the Vasculature. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 653-661.
53. Hilenski, L.L.; Clempus, R.E.; Quinn, M.T.; Lambeth, J.D.; Griendling, K.K. Distinct subcellular localizations of nox1 and nox4 in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 677-683.
54. Babior, B.M. NADPH oxidase. Curr. Opin. Immunol. 2004, 16, 42-47.
55. Miyano, K.; Sumimoto, H. Role of the small GTPase Rac in p22phox-dependent NADPH oxidases. Biochimie 2007, 89, 1133-44.
56. Hordijk, P.L. Regulation of NADPH oxidases: The role of Rac proteins. Circ. Res. 2006, 98, 453-462.
57. Janiszewski, M.; Lopes, L.R.; Carmo, A.O.; Pedro, M.A.; Brandes, R.P.; Santos, C.X.; Laurindo, F.R. Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J. Biol. Chem. 2005, 280, 40813-40819.
58. Miller, F.J., Jr.; Filali, M.; Huss, G.J.; Stanic, B.; Chamseddine, A.; Barna, T.J.; Lamb, F.S. Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ. Res. 2007, 101, 663-671.
59. Moreland, J.G.; Davis, A.P.; Matsuda, J.J.; Hook, J.S.; Bailey, G.; Nauseef, W.M.; Lamb, F.S. Endotoxin priming of neutrophils requires NADPH oxidase-generated oxidants and is regulated by the anion transporter ClC-3. J. Biol. Chem. 2007, 282, 33958-33967.
60. Lyle, A.N.; Deshpande, N.N.; Taniyama, Y.; Seidel-Rogol, B.; Pounkova, L.; Du, P.; Papaharalambus, C.; Lassegue, B.; Griendling, K.K. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ. Res. 2009, 105, 249-259.
61. Manickam, N.; Patel, M.; Griendling, K.K.; Gorin, Y.; Barnes, J.L. RhoA/Rho kinase mediates TGF-β-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species. Am. J. Physiol. Renal. Physiol. 2014, 307, doi:10.1152/ajprenal.00546.2013.
62. Martinez-Lemus, L.A.; Zhao, G.; Galiñanes, E.L.; Boone, M. Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases. Am. J. Physiol. Heart Circ. Physiol. 2011, 300, H2005-H2015.
63. Brandes, R.P.; Kreuzer, J. Vascular NADPH oxidases: Molecular mechanisms of activation. Cardiovasc. Res. 2005, 65, 16-27.
64. Brandes, R.P.; Schroder, K. Differential vascular functions of Nox family NADPH oxidases. Curr. Opin. Lipidol. 2008, 19, 513-518.
65. Brandes, R.P.; Weissmann, N.; Schroder, K. Nox family NADPH oxidases: Molecular mechanisms of activation. Free Radic. Biol. Med. 2014, 76, 208-226.
66. Martinez-Lemus, L.A. Persistent agonist-induced vasoconstriction is not required for angiotensin II to mediate inward remodeling of isolated arterioles with myogenic tone. J. Vasc. Res. 2008, 45, 211-221.
67. Briones, A.M.; Tabet, F.; Callera, G.E.; Montezano, A.C.; Yogi, A.; He, Y.; Quinn, M.T.; Salaices, M.; Touyz, R.M., Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. J. Am. Soc. Hypertens. 2011, 5, 137-153.
68. Beswick, R.A.; Dorrance, A.M.; Leite, R.; Webb, R.C., NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 2001, 38, 1107-1111.
69. Fujii, A.; Nakano, D.; Katsuragi, M.; Ohkita, M.; Takaoka, M.; Ohno, Y.; Matsumura, Y. Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension. Eur. J. Pharmcol. 2006, 552, 131-134.
70. Polichnowski, A.J.; Jin, C.; Yang, C.; Cowley, A.W. Role of renal perfusion pressure versus angiotensin ii on renal oxidative stress in angiotensin II-induced hypertensive rats. Hypertension 2010, 55, 1425-1430.
71. Zhou, M.S.; Jaimes, E.A.; Raij, L. Vascular but not cardiac remodeling is associated with superoxide production in angiotensin II hypertension. J. Hypertens. 2005, 23, 1737-1743.
72. Bonacasa, B.; Sanchez, M.L.; Rodriguez, F.; Lopez, B.; Quesada, T.; Fenoy, F.J.; Hernandez, I. 2-Methoxyestradiol attenuates hypertension and coronary vascular remodeling in spontaneously hypertensive rats. Maturitas 2008, 61, 310-316.
73. Chignalia, A.Z.; Schuldt, E.Z.; Camargo, L.L.; Montezano, A.C.; Callera, G.E.; Laurindo, F.R.; Lopes, L.R.; Avellar, M.C.W.; Carvalho, M.H.C.; Fortes, Z.B., et al. Testosterone induces vascular smooth muscle cell migration by NADPH oxidase and c-Src-dependent pathways. Hypertension 2012, 59, 1263-1271.
74. Diep, Q.N.; Amiri, F.; Touyz, R.M.; Cohn, J.S.; Endemann, D.; Neves, M.F.; Schiffrin, E.L. PPARα activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 2002, 40, 866-871.
75. Marchesi, C.; Rehman, A.; Rautureau, Y.; Kasal, D.A.; Briet, M.; Leibowitz, A.; Simeone, S.M.C.; Ebrahimian, T.; Neves, M.F.; Offermanns, S., et al. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease. Cardiovasc. Res. 2013, 97, 562-570.
76. Carlström, M.; Lai, E.Y.; Ma, Z.; Steege, A.; Patzak, A.; Eriksson, U.J.; Lundberg, J.O.; Wilcox, C.S.; Persson, A.E.G. Superoxide dismutase 1 limits renal microvascular remodeling and attenuates arteriole and blood pressure responses to angiotensin II via modulation of nitric oxide bioavailability. Hypertension 2010, 56, 907-913.
77. Virdis, A.; Neves, M.F.; Amiri, F.; Touyz, R.M.; Schiffrin, E.L. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J. Hypertens. 2004, 22, 535-542.
78. Ito, N.; Ohishi, M.; Yamamoto, K.; Tatara, Y.; Shiota, A.; Hayashi, N.; Komai, N.; Yanagitani, Y.; Rakugi, H.; Ogihara, T. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats. Am. J. Hypertens. 2007, 20, 792-799.
79. Briones, A.M.; Rodriguez-Criado, N.; Hernanz, R.; Garcia-Redondo, A.B.; Rodrigues-Diez, R.R.; Alonso, M.J.; Egido, J.; Ruiz-Ortega, M.; Salaices, M. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress. Hypertension 2009, 54, 142-149.
80. Chen, J.-X.; Zeng, H.; Tuo, Q.-H.; Yu, H.; Meyrick, B.; Aschner, J.L. NADPH oxidase modulates myocardial Akt, ERK1/2 activation, and angiogenesis after hypoxia-reoxygenation. Am. J. Physiol. Heart Circ. Physiol. 2007, 292, H1664-H1674.
81. Kim, Y.M.; Kim, K.E.; Koh, G.Y.; Ho, Y.-S.; Lee, K.-J. Hydrogen peroxide produced by angiopoietin-1 mediates angiogenesis. Cancer Res. 2006, 66, 6167-6174.
82. Ago, T.; Kuroda, J.; Kamouchi, M.; Sadoshima, J.; Kitazono, T. Pathophysiological roles of NADPH oxidase/Nox family proteins in the vascular system review and perspective. Circ. J. 2011, 75, 1791-1800.
83. Bir, S.C.; Kolluru, G.K.; Fang, K.; Kevil, C.G. Redox balance dynamically regulates vascular growth and remodeling. Semin. Cell Dev. Biol. 2012, 23, 745-757.
84. Wilkinson-Berka, J.L.; Rana, I.; Armani, R.; Agrotis, A. Reactive oxygen species, Nox and angiotensin II in angiogenesis: Implications for retinopathy. Clin. Sci. 2013, 124, 597-615.
85. Catani, M.V.; Bernassola, F.; Rossi, A.; Melino, G. Inhibition of clotting factor XIII activity by nitric oxide. Biochem. Biophys. Res. Commun. 1998, 249, 275-278.
86. Kubes, P.; Kanwar, S.; Niu, X.F.; Gaboury, J.P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 1993, 7, 1293-1299.
87. Kurose, I.; Wolf, R.; Grisham, M.B.; Tak Yee, A.; Specian, R.D.; Granger, D.N. Microvascular responses to inhibition of nitric oxide production: Role of active oxidants. Circ. Res. 1995, 76, 30-39.
88. Zou, M.H.; Cohen, R.A.; Ullrich, V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 2004, 11, 89-97.
89. Tsihlis, N.D.; Oustwani, C.S.; Vavra, A.K.; Jiang, Q.; Keefer, L.K.; Kibbe, M.R. Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of ubcH10. Cell. Biochem. Biophys. 2011, 60, 89-97.
90. Marchesi, C.; Ebrahimian, T.; Angulo, O.; Paradis, P.; Schiffrin, E.L. Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension 2009, 54, 1384-1392.
91. Chandra, S.; Romero, M.J.; Shatanawi, A.; Alkilany, A.M.; Caldwell, R.B.; Caldwell, R.W. Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway. Br. J. Pharmacol. 2012, 165, 506-519.
92. Shin, W.; Berkowitz, D.E.; Ryoo, S., Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice. Exp. Mol. Med. 2012, 44, 594-602.
93. Werner-Felmayer, G.; Werner, E.R.; Fuchs, D.; Hausen, A.; Reibnegger, G.; Schmidt, K.; Weiss, G.; Wachter, H. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J. Biol. Chem. 1993, 268, 1842-1846.
94. Landmesser, U.; Dikalov, S.; Price, S.R.; McCann, L.; Fukai, T.; Holland, S.M.; Mitch, W.E.; Harrison, D.G. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Investig. 2003, 111, 1201-1209.
95. Shinozaki, K.; Kashiwagi, A.; Nishio, Y.; Okamura, T.; Yoshida, Y.; Masada, M.; Toda, N.; Kikkawa, R. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2− imbalance in insulin-resistant rat aorta. Diabetes 1999, 48, 2437-2445.
96. Hong, H.-J.; Hsiao, G.; Cheng, T.-H.; Yen, M.-H. Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 2001, 38, 1044-1048.
97. Heitzer, T.; Krohn, K.; Albers, S.; Meinertz, T. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia 2000, 43, 1435-1438.
98. Higashi, Y.; Sasaki, S.; Nakagawa, K.; Fukuda, Y.; Matsuura, H.; Oshima, T.; Chayama, K. Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. Am. J. Hypertens. 2002, 15, 326-332.
99. Milstien, S.; Katusic, Z. Oxidation of tetrahydrobiopterin by peroxynitrite: Implications for vascular endothelial function. Biochem. Biophys. Res. Commun. 1999, 263, 681-684.
100. Laursen, J.B.; Somers, M.; Kurz, S.; McCann, L.; Warnholtz, A.; Freeman, B.A.; Tarpey, M.; Fukai, T.; Harrison, D.G. Endothelial regulation of vasomotion in apoE-deficient mice: Implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 2001, 103, 1282-1288.
101. Du, Y.H.; Guan, Y.Y.; Alp, N.J.; Channon, K.M.; Chen, A.F. Endothelium-specific GTP cyclohydrolase i overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension. Circulation 2008, 117, 1045-1054.
102. Crabtree, M.J.; Tatham, A.L.; Hale, A.B.; Alp, N.J.; Channon, K.M. Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: Relative importance of the de novo biopterin synthesis versus salvage pathways. J. Biol. Chem. 2009, 284, 28128-28136.
103. Chalupsky, K.; Cai, H. Endothelial dihydrofolate reductase: Critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 2005, 102, 9056-9061.
104. Youn, J.Y.; Gao, L.; Cai, H. The p47 phox-and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes. Diabetologia 2012, 55, 2069-2079.
105. Stipek, S.; Novak, L.; Crkovska, J.; Zima, T.; Platenik, J. Xanthine oxidoreductase. Biochemical, biological and pathogenic functions. Sb. Lek. 1994, 95, 289-295.
106. Garattini, E.; Mendel, R.; Romão, M.J.; Wright, R.; Terao, M. Mammalian molybdo-flavoenzymes, an expanding family of proteins: Structure, genetics, regulation, function and pathophysiology. Biochem. J. 2003, 372, 15-32.
107. Berry, C.E.; Hare, J.M. Xanthine oxidoreductase and cardiovascular disease: Molecular mechanisms and pathophysiological implications. J. Physiol. 2004, 555, 589-606.
108. Sakuma, S.; Fujimoto, Y.; Sakamoto, Y.; Uchiyama, T.; Yoshioka, K.; Nishida, H.; Fujita, T. Peroxynitrite induces the conversion of xanthine dehydrogenase to oxidase in rabbit liver. Biochem. Biophys. Res. Commun. 1997, 230, 476-479.
109. Kuwabara, Y.; Nishino, T.; Okamoto, K.; Matsumura, T.; Eger, B.T.; Pai, E.F. Unique amino acids cluster for switching from the dehydrogenase to oxidase form of xanthine oxidoreductase. Proc. Natl. Acad. Sci. USA 2003, 100, 8170-8175.
110. Kelley, E.E.; Khoo, N.K. H.; Hundley, N.J.; Malik, U.Z.; Freeman, B.A.; Tarpey, M.M. Hydrogen peroxide is the major oxidant product of xanthine oxidase. Free Radic. Biol. Med. 2010, 48, 493-498.
111. Landmesser, U.; Spiekermann, S.; Preuss, C.; Sorrentino, S.; Fischer, D.; Manes, C.; Mueller, M.; Drexler, H. Angiotensin II induces endothelial xanthine oxidase activation: Role for endothelial dysfunction in patients with coronary disease. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 943-948.
112. McNally, J.S.; Davis, M.E.; Giddens, D.P.; Saha, A.; Hwang, J.; Dikalov, S.; Jo, H.; Harrison, D.G. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am. J. Physiol. Heart Circ. Physiol. 2003, 285, H2290-H2297.
113. Kou, B.; Ni, J.; Vatish, M.; Singer, D.R. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis. Microcirculation 2008, 15, 251-267.
114. Jankov, R.P.; Kantores, C.; Pan, J.; Belik, J. Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294, L233-L245.
115. Suzuki, H.; Delano, F.A.; Parks, D.A.; Jamshidi, N.; Granger, D.N.; Ishii, H.; Suematsu, M.; Zweifach, B.W.; Schmid-Schönbein, G.W. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc. Natl. Acad. Sci. USA 1998, 95, 4754-4759.
116. Swei, A.; Lacy, F.; Delano, F.A.; Parks, D.A.; Schmid-Schönbein, G.W. A mechanism of oxygen free radical production in the Dahl hypertensive rat. Microcirculation 1999, 6, 179-187.
117. Ong, S.L. H.; Vickers, J.J.; Zhang, Y.; McKenzie, K.U. S.; Walsh, C.E.; Whitworth, J.A. Role of xanthine oxidase in dexamethasone-induced hypertension in rats. Clin. Exp. Pharmacol. Physiol. 2007, 34, 517-519.
118. Zhang, W.; Wu, Y.; Wu, C.; Gunst, S.J., Integrin-linked kinase regulates N-WASp-mediated actin polymerization and tension development in tracheal smooth muscle. J. Biol. Chem. 2007, 282, 34568-34580.
119. Lustgarten, M.S.; Bhattacharya, A.; Muller, F.L.; Jang, Y.C.; Shimizu, T.; Shirasawa, T.; Richardson, A.; van Remmen, H., Complex I generated, mitochondrial matrix-directed superoxide is released from the mitochondria through voltage dependent anion channels. Biochem. Biophys. Res. Commun. 2012, 422, 515-521.
120. Aon, M.A.; Cortassa, S.; O’Rourke, B. Percolation and criticality in a mitochondrial network. Proc. Natl. Acad. Sci. USA 2004, 101, 4447-4452.
121. Xia, C.; Meng, Q.; Liu, L.Z.; Rojanasakul, Y.; Wang, X.R.; Jiang, B.H. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res. 2007, 67, 10823-10830.
122. Rathore, R.; Zheng, Y.-M.; Niu, C.-F.; Liu, Q.-H.; Korde, A.; Ho, Y.-S.; Wang, Y.-X. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCɛ signaling axis in pulmonary artery smooth muscle cells. Free Radic. Biol. Med. 2008, 45, 1223-1231.
123. Viel, E.C.; Benkirane, K.; Javeshghani, D.; Touyz, R.M.; Schiffrin, E.L. Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 2008, 295, H281-H288.
124. Choi, H.; Tostes, R.C.; Webb, R.C. Mitochondrial aldehyde dehydrogenase prevents ROS-induced vascular contraction in angiotensin-II hypertensive mice. J. Am. Soc. Hypertens. 2011, 5, 154-160.
125. Doughan, A.K.; Harrison, D.G.; Dikalov, S.I. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: Linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 2008, 102, 488-496.
126. Wang, J.N.; Shi, N.; Chen, S.Y. Manganese superoxide dismutase inhibits neointima formation through attenuation of migration and proliferation of vascular smooth muscle cells. Free Radic. Biol. Med. 2012, 52, 173-181.
127. Intengan, H.D.; Schiffrin, E.L. Vascular remodeling in hypertension: Roles of apoptosis, inflammation, and fibrosis. Hypertension 2001, 38, 581-587.
128. Kumai, Y.; Ooboshi, H.; Ago, T.; Ishikawa, E.; Takada, J.; Kamouchi, M.; Kitazono, T.; Ibayashi, S.; Iida, M. Protective effects of angiotensin II Type 1 receptor blocker on cerebral circulation independent of blood pressure. Exp. Neurol. 2008, 210, 441-448.
129. Bonacasa, B.; Hernández, I.; Fenoy, F.J.; Quesada, T.; López, B. Effect of tempol on myocardial vascular remodeling in female spontaneously hypertensive rats. Histol. Histopathol. 2012, 27, 1047-1054.
130. Pires, P.W.; Deutsch, C.; McClain, J.L.; Rogers, C.T.; Dorrance, A.M. Tempol, a superoxide dismutase mimetic, prevents cerebral vessel remodeling in hypertensive rats. Microvasc. Res. 2010, 80, 445-452.
131. Touyz, R.M.; Schiffrin, E.L. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: Role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J. Hypertens. 2001, 19, 1245-1254.
132. Belin De Chantemèle, E.J.; Vessières, E.; Guihot, A.L.; Toutain, B.; Maquignau, M.; Loufrani, L.; Henrion, D. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow. Cardiovasc. Res. 2009, 81, 788-796.
133. Baron-Menguy, C.; Toutain, B.; Cousin, M.; Dumont, O.; Guihot, A.L.; Vessières, E.; Subra, J.F.; Custaud, M.A.; Loufrani, L.; Henrion, D. Involvement of angiotensin II in the remodeling induced by a chronic decrease in blood flow in rat mesenteric resistance arteries. Hypertens. Res. 2010, 33, 857-866.
134. Freidja, M.L.; Vessieres, E.; Clere, N.; Desquiret, V.; Guihot, A.L.; Toutain, B.; Loufrani, L.; Jardel, A.; Procaccio, V.; Faure, S., et al. Heme oxygenase-1 induction restores high-blood-flowdependent remodeling and endothelial function in mesenteric arteries of old rats. J. Hypertens. 2011, 29, 102-112.
135. Freidja, M.L.; Toutain, B.; Caillon, A.; Desquiret, V.; Lambert, D.; Loufrani, L.; Procaccio, V.; Henrion, D. Heme oxygenase 1 is differentially involved in blood flow-dependent arterial remodeling: Role of inflammation, oxidative stress, and nitric oxide. Hypertension 2011, 58, 225-231.
136. Cousin, M.; Custaud, M.A.; Baron-Menguy, C.; Toutain, B.; Dumont, O.; Guihot, A.L.; Vessieres, E.; Subra, J.F.; Henrion, D.; Loufrani, L. Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries. Hypertension 2010, 55, 109-115.
137. Bouvet, C.; de Chantemèle, E.B.; Guihot, A.L.; Vessières, E.; Bocquet, A.; Dumont, O.; Jardel, A.; Loufrani, L.; Moreau, P.; Henrion, D., Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension 2007, 50, 248-254.
138. Belin De Chanteméle, E.; Vessiéres, E.; Dumont, O.; Guihot, A.L.; Toutain, B.; Loufrani, L.; Henrion, D. Reactive oxygen species are necessary for high flow (shear Stress)-induced diameter enlargement of rat resistance arteries. Microcirculation 2009, 16, 391-402.
139. Lv, P.; Miao, S.B.; Shu, Y.N.; Dong, L.H.; Liu, G.; Xie, X.L.; Gao, M.; Wang, Y.C.; Yin, Y.J.; Wang, X.J., et al. Phosphorylation of smooth muscle 22α facilitates angiotensin II-induced ROS production via activation of the PKCδ-P47phox axis through release of PKCδ and actin dynamics and is associated with hypertrophy and hyperplasia of vascular smooth muscle cells in vitro and in vivo. Circ. Res. 2012, 111, 697-707.
140. Murdoch, C.E.; Alom-Ruiz, S.P.; Wang, M.; Zhang, M.; Walker, S.; Yu, B.; Brewer, A.; Shah, A.M. Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction. Basic Res. Cardiol. 2011, 106, 527-538.
141. Sakurada, T.; Ishizawa, K.; Imanishi, M.; Izawa-Ishizawa, Y.; Fujii, S.; Tominaga, E.; Tsuneishi, T.; Horinouchi, Y.; Kihira, Y.; Ikeda, Y., et al. Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects. Naunyn. Schmiedebergs Arch. Pharmacol. 2013, 386, 29-39.
142. Bakker, E.N.T.P.; Matlung, H.L.; Bonta, P.; de Vries, C.J.; van Rooijen, N.; Vanbavel, E. Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone. Cardiovasc. Res. 2008, 78, 341-348.
143. Zhang, H.; Pakeerappa, P.; Lee, H.J.; Fisher, S.A. Induction of PDE5 and de-sensitization to endogenous NO signaling in a systemic resistance artery under altered blood flow. J. Mol. Cell. Cardiol. 2009, 47, 57-65.
144. Haas, T.L.; Doyle, J.L.; Distasi, M.R.; Norton, L.E.; Sheridan, K.M.; Unthank, J.L. Involvement of MMPs in the outward remodeling of collateral mesenteric arteries. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H2429-H2437.
145. Castier, Y.; Brandes, R.P.; Leseche, G.; Tedgui, A.; Lehoux, S. p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. Circ. Res. 2005, 97, 533-540.
146. Freidja, M.L.; Tarhouni, K.; Toutain, B.; Fassot, C.; Loufrani, L.; Henrion, D. The AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes. Diabetes 2012, 61, 1562-1572.
147. Gao, L.; Mann, G.E. Vascular NAD(P)H oxidase activation in diabetes: A double-edged sword in redox signalling. Cardiovasc. Res. 2009, 82, 9-20.
148. Rensen, S.S.M.; Doevendans, P.A.F.M.; van Eys, G.J.J.M. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth. Heart J. 2007, 15, 100-108.
149. Hu, W.Y.; Fukuda, N.; Kanmatsuse, K. Growth characteristics, angiotensin II generation, and microarray-determined gene expression in vascular smooth muscle cells from young spontaneously hypertensive rats. J. Hypertens. 2002, 20, 1323-1333.
150. Lin, Z.H.; Fukuda, N.; Jin, X.Q.; Yao, E.H.; Ueno, T.; Endo, M.; Saito, S.; Matsumoto, K.; Mugishima, H. Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 2004, 44, 42-47.
151. Fujita, Y.; Lin, J.X.; Takahashi, R.; Tomimoto, H. Cilostazol alleviates cerebral small-vessel pathology and white-matter lesions in stroke-prone spontaneously hypertensive rats. Brain Res. 2008, 1203, 170-176.
152. Nagai, Y.; Saito, Y.; Hamada, K.; Hara, N.; Nakanishi, K.; Masaki, K.; Tanaka, M.; Ger, Y.C.; Nakamura, K. Renal vascular walls in patients with preeclampsia superimposed on essential hypertension. Am. J. Kidney Dis. 2001, 37, 728-735.
153. Quarck, R.; Wynants, M.; Ronisz, A.; Sepulveda, M.R.; Wuytack, F.; van Raemdonck, D.; Meyns, B.; Delcroix, M. Characterization of proximal pulmonary arterial cells from chronic thromboembolic pulmonary hypertension patients. Respir. Res. 2012, 13, doi:10.1186/1465-9921-13-27
154. Owens, G.K.; Kumar, M.S.; Wamhoff, B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84, 767-801.
155. Martinez-Lemus, L.A.; Hill, M.A.; Bolz, S.S.; Pohl, U.; Meininger, G.A. Acute mechanoadaptation of vascular smooth muscle cells in response to continuous arteriolar vasoconstriction: Implications for functional remodeling. FASEB J. 2004, 18, 708-710.
156. De la Cuesta, F.; Zubiri, I.; Maroto, A.S.; Posada, M.; Padial, L.R.; Vivanco, F.; Alvarez-Llamas, G.; Barderas, M.G. Deregulation of smooth muscle cell cytoskeleton within the human atherosclerotic coronary media layer. J. Proteomics 2013, 82, 155-165.
157. Itoh, S.; Umemoto, S.; Hiromoto, M.; Toma, Y.; Tomochika, Y.; Aoyagi, S.; Tanaka, M.; Fujii, T.; Matsuzaki, M. Importance of NAD(P)H oxidase-mediated oxidative stress and contractile type smooth muscle myosin heavy chain SM2 at the early stage of atherosclerosis. Circulation 2002, 105, 2288-2295.
158. Absood, A.; Furutani, A.; Kawamura, T.; Graham, L.M. Differential PDGF secretion by graft and aortic SMC in response to oxidized LDL. Am. J. Physiol. Heart Circ. Physiol. 2002, 283, H725-H732.
159. Ashino, T.; Yamamoto, M.; Yoshida, T.; Numazawa, S. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 760-768.
160. Patel, R.; Cardneau, J.D.; Colles, S.M.; Graham, L.M. Synthetic smooth muscle cell phenotype is associated with increased nicotinamide adenine dinucleotide phosphate oxidase activity: Effect on collagen secretion. J. Vasc. Surg. 2006, 43, 364-371.
161. Touré, F.; Fritz, G.; Li, Q.; Rai, V.; Daffu, G.; Zou, Y.S.; Rosario, R.; Ramasamy, R.; Alberts, A.S.; Yan, S.F., et al. Formin mDia1 mediates vascular remodeling via integration of oxidative and signal transduction pathways. Circ. Res. 2012, 110, 1279-1293.
162. Sung, H.J.; Eskin, S.G.; Sakurai, Y.; Yee, A.; Kataoka, N.; McIntire, L.V. Oxidative stress produced with cell migration increases synthetic phenotype of vascular smooth muscle cells. Ann. Biomed. Eng. 2005, 33, 1546-1554.
163. Su, B.; Mitra, S.; Gregg, H.; Flavahan, S.; Chotani, M.A.; Clark, K.R.; Goldschmidt-Clermont, P.J.; Flavahan, N.A. Redox regulation of vascular smooth muscle cell differentiation. Circ. Res. 2001, 89, 39-46.
164. Lee, M.Y.; Griendling, K.K. Redox signaling, vascular function, and hypertension. Antioxid. Redox Signal. 2008, 10, 1045-1059.
165. Dikalov, S.I.; Dikalova, A.E.; Bikineyeva, A.T.; Schmidt, H.H.H.W.; Harrison, D.G.; Griendling, K.K. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic. Biol. Med. 2008, 45, 1340-1351.
166. Mittal, M.; Roth, M.; König, P.; Hofmann, S.; Dony, E.; Goyal, P.; Selbitz, A.C.; Schermuly, R.T.; Ghofrani, H.A.; Kwapiszewska, G., et al. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ. Res. 2007, 101, 258-267.
167. Clempus, R.E.; Sorescu, D.; Dikalova, A.E.; Pounkova, L.; Jo, P.; Sorescu, G.P.; Lassègue, B.; Griendling, K.K. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 42-48.
168. Zuckerbraun, B.S.; Stoyanovsky, D.A.; Sengupta, R.; Shapiro, R.A.; Ozanich, B.A.; Rao, J.; Barbato, J.E.; Tzeng, E. Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA. Am. J. Physiol.Cell. Physiol. 2007, 292, C824-C831.
169. Majesky, M.W. Developmental basis of vascular smooth muscle diversity. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1248-1258.
170. Zhang, H.; Facemire, C.S.; Banes, A.J.; Faber, J.E. Different alpha-adrenoceptors mediate migration of vascular smooth muscle cells and adventitial fibroblasts in vitro. Am. J. Physiol. Heart Circ. Physiol. 2002, 282, H2364-H2370.
171. Nishio, E.; Watanabe, Y. The involvement of reactive oxygen species and arachidonic acid in alpha 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br. J. Pharmacol 1997, 121, 665-670.
172. Xi, X.P.; Graf, K.; Goetze, S.; Fleck, E.; Hsueh, W.A.; Law, R.E. Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 73-82.
173. Kim, N.; Hwangbo, C.; Lee, S.; Lee, J.H. Eupatolide inhibits PDGF-induced proliferation and migration of aortic smooth muscle cells through ROS-dependent heme oxygenase-1 induction. Phytother. Res. 2013, 27, 1700-1707.
174. Wang, Z.; Castresana, M.R.; Newman, W.H. Reactive oxygen and NF-κB in VEGF-induced migration of human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 2001, 285, 669-674.
175. Wang, Z.; Castresana, M.R.; Newman, W.H. Reactive oxygen species-sensitive p38 MAPK controls thrombin-induced migration of vascular smooth muscle cells. J. Mol. Cell. Cardiol. 2004, 36, 49-56.
176. Xu, S.; Shriver, A.S.; Jagadeesha, D.K.; Chamseddine, A.H.; Szócs, K.; Weintraub, N.L.; Griendling, K.K.; Bhalla, R.C.; Miller, F.J.; Increased expression of Nox1 in neointimal smooth muscle cells promotes activation of matrix metalloproteinase-9. J. Vasc. Res. 2012, 49, 242-248.
177. Hsieh, C.C.; Lau, Y.T. Migration of vascular smooth muscle cells is enhanced in cultures derived from spontaneously hypertensive rat. Pflugers Arch. 1998, 435, 286-292.
178. Lee, H.M.; Kim, H.J.; Won, K.J.; Choi, W.S.; Lee, K.Y.; Bae, Y.M.; Park, P.J.; Park, T.K.; Lee, Y.L.; Lee, C.K., et al. Contribution of soluble intercellular adhesion molecule-1 to the migration of vascular smooth muscle cells. Eur. J. Pharmcol. 2008, 579, 260-268.
179. Zhang, L.; Xie, P.; Wang, J.; Yang, Q.; Fang, C.; Zhou, S.; Li, J. Impaired peroxisome proliferator-activated receptor-γ contributes to phenotypic modulation of vascular smooth muscle cells during hypertension. J. Biol. Chem. 2010, 285, 13666-13677.
180. Zhao, J.; Kyotani, Y.; Ito, S.; Nagayama, K.; Ozawa, K.; Yoshizumi, M. Comparison of the effects of Src inhibition and mitogen-activated protein kinase inhibition on the migration of vascular smooth muscle cells stimulated by angiotensin II. J. Nara Med. Assoc. 2012, 63, 25-35.
181. Panchatcharam, M.; Miriyala, S.; Yang, F.; Leitges, M.; Chrzanowska-Wodnicka, M.; Quilliam, L.A.; Anaya, P.; Morris, A.J.; Smyth, S.S. Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by β3 integrin signaling. Int. J. Biochem. Cell. Biol. 2010, 42, 965-974.
182. Watson, P.A.; Nesterova, A.; Burant, C.F.; Klemm, D.J.; Reusch, J.E.B. Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration. J. Biol. Chem. 2001, 276, 46142-46150.
183. Yamaguchi, H.; Igarashi, M.; Hirata, A.; Sugae, N.; Tsuchiya, H.; Jimbu, Y.; Tominaga, M.; Kato, T. Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: Roles of protein kinase C-δ. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 2095-2101.
184. Sundaresan, M.; Yu, Z.X.; Ferrans, V.J.; Irani, K.; Finkel, T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995, 270, 296-299.
185. Abhijit, S.; Bhaskaran, R.; Narayanasamy, A.; Chakroborty, A.; Manickam, N.; Dixit, M.; Mohan, V.; Balasubramanyam, M. Hyperinsulinemia-induced vascular smooth muscle cell (VSMC) migration and proliferation is mediated by converging mechanisms of mitochondrial dysfunction and oxidative stress. Mol. Cell. Biochem. 2013, 373, 95-105.
186. Jagadeesha, D.K.; Takapoo, M.; Banfi, B.; Bhalla, R.C.; Miller, F.J., Jr. Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration. Cardiovasc. Res. 2012, 93, 406-413.
187. Mac Gabhann, F.; Peirce, S.M. Collateral capillary arterialization following arteriolar ligation in murine skeletal muscle. Microcirculation 2010, 17, 333-347.
188. Unthank, J.L.; Fath, S.W.; Burkhart, H.M.; Miller, S.C.; Dalsing, M.C. Wall remodeling during luminal expansion of mesenteric arterial collaterals in the rat. Circ. Res. 1996, 79, 1015-1023.
189. Wolf, C.; Cai, W.J.; Vosschulte, R.; Koltai, S.; Mousavipour, D.; Scholz, D.; Afsah-Hedjri, A.; Schaper, W.; Schaper, J. Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J. Mol. Cell. Cardiol. 1998, 30, 2291-305.
190. Gerthoffer, W.T. Mechanisms of vascular smooth muscle cell migration. Circ. Res. 2007, 100, 607-621.
191. Hong, Z.; Sun, Z.; Li, M.; Li, Z.; Bunyak, F.; Ersoy, I.; Trzeciakowski, J.P.; Staiculescu, M.C.; Jin, M.; Martinez-Lemus, L., et al. Vasoactive agonists exert dynamic and coordinated effects on vascular smooth muscle cell elasticity, cytoskeletal remodelling and adhesion. J. Physiol. 2014, 592, 1249-1266.
192. Hong, Z.; Sun, Z.; Li, Z.; Mesquitta, W.T.; Trzeciakowski, J.P.; Meininger, G.A. Coordination of fibronectin adhesion with contraction and relaxation in microvascular smooth muscle. Cardiovasc. Res. 2012, 96, 73-80.
193. Yamin, R.; Morgan, K.G. Deciphering actin cytoskeletal function in the contractile vascular smooth muscle cell. J. Physiol. 2012, 590, 4145-4154.
194. Lehman, W.; Morgan, K.G. Structure and dynamics of the actin-based smooth muscle contractile and cytoskeletal apparatus. J. Muscle Res. Cell. Motil. 2012, 33, 461-469
195. Castorena-Gonzalez, J.A.; Staiculescu, M.C.; Foote, C.A.; Polo-Parada, L.; Martinez-Lemus, L.A. The obligatory role of the actin cytoskeleton on inward remodeling induced by dithiothreitol activation of endogenous transglutaminase in isolated arterioles. Am. J. Physiol. Heart Circ. Physiol. 2014, 306, H485-H495.
196. Gunst, S.J.; Zhang, W. Actin cytoskeletal dynamics in smooth muscle: A new paradigm for the regulation of smooth muscle contraction. Am. J. Physiol. Cell. Physiol. 2008, 295, C576-C587.
197. Crawford, L.E.; Milliken, E.E.; Irani, K.; Zweier, J.L.; Becker, L.C.; Johnson, T.M.; Eissa, N.T.; Crystal, R.G.; Finkel, T.; Goldschmidt-Clermont, P.J. Superoxide-mediated actin response in post-hypoxic endothelial cells. J. Biol. Chem. 1996, 271, 26863-26867.
198. Zweier, J.L.; Broderick, R.; Kuppusamy, P.; Thompson-Gorman, S.; Lutty, G.A. Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation. J. Biol. Chem. 1994, 269, 24156-24162.
199. Moldovan, L.; Moldovan, N.I.; Sohn, R.H.; Parikh, S.A.; Goldschmidt-Clermont, P.J. Redox changes of cultured endothelial cells and actin dynamics. Circ. Res. 2000, 86, 549-557.
200. Firat-Karalar, E.N.; Welch, M.D. New mechanisms and functions of actin nucleation. Curr. Opin. Cell. Biol. 2011, 23, 4-13.
201. Zhang, W.; Wu, Y.; Du, L.; Tang, D.D.; Gunst, S.J. Activation of the Arp2/3 complex by N-WASp is required for actin polymerization and contraction in smooth muscle. Am. J. Physiol. Cell. Physiol. 2005, 288, C1145-C1460.
202. Tang, D.D.; Zhang, W.; Gunst, S.J. The adapter protein CrkII regulates neuronal Wiskott-Aldrich syndrome protein, actin polymerization, and tension development during contractile stimulation of smooth muscle. J. Biol. Chem. 2005, 280, 23380-23389.
203. Anfinogenova, Y.; Wang, R.; Li, Q.F.; Spinelli, A.M.; Tang, D.D. Abl silencing inhibits CAS-mediated process and constriction in resistance arteries. Circ. Res. 2007, 101, 420-428.
204. Al Ghouleh, I.; Rodriguez, A.; Pagano, P.J.; Csanyi, G. Proteomic analysis identifies an NADPH oxidase 1 (Nox1)-mediated role for actin-related protein 2/3 complex subunit 2 (ARPC2) in promoting smooth muscle cell migration. Int. J. Mol. Sci. 2013, 14, 20220-20235.
205. Kaverina, I.; Stradal, T.E.; Gimona, M. Podosome formation in cultured A7r5 vascular smooth muscle cells requires Arp2/3-dependent de-novo actin polymerization at discrete microdomains. J. Cell Sci. 2003, 116, 4915-4924.
206. DalleDonne, I.; Milzani, A.; Colombo, R. H2O2-treated actin: Assembly and polymer interactions with cross-linking proteins. Biophys. J. 1995, 69, 2710-2719.
207. Milzani, A.; DalleDonne, I.; Colombo, R. Prolonged oxidative stress on actin. Arch. Biochem. Biophys. 1997, 339, 267-274.
208. Huot, J.; Houle, F.; Marceau, F.; Landry, J. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ. Res. 1997, 80, 383-392.
209. Aghajanian, A.; Wittchen, E.S.; Campbell, S.L.; Burridge, K. Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PLoS One 2009, 4, e8045.
210. Jaffe, A.B.; Hall, A. Rho GTPases: Biochemistry and biology. Annu. Rev. Cell. Dev. Biol. 2005, 21, 247-69.
211. Ten Klooster, J.P.; Evers, E.E.; Janssen, L.; Machesky, L.M.; Michiels, F.; Hordijk, P.; Collard, J.G. Interaction between Tiam1 and the Arp2/3 complex links activation of Rac to actin polymerization. Biochem. J. 2006, 397, 39-45.
212. Millius, A.; Watanabe, N.; Weiner, O.D. Diffusion, capture and recycling of SCAR/WAVE and Arp2/3 complexes observed in cells by single-molecule imaging. J. Cell. Sci 2012, 125, 1165-1176.
213. Kraemer, A.; Goodwin, M.; Verma, S.; Yap, A.S.; Ali, R.G. Rac is a dominant regulator of cadherin-directed actin assembly that is activated by adhesive ligation independently of Tiam1. Am. J. Physiol. Cell. Physiol. 2007, 292, C1061-C1069.
214. Sun, H.; Schlondorff, J.S.; Brown, E.J.; Higgs, H.N.; Pollak, M.R. Rho activation of mDia formins is modulated by an interaction with inverted formin 2 (INF2). Proc. Natl. Acad. Sci. USA 2011, 108, 2933-2938.
215. Otomo, T.; Otomo, C.; Tomchick, D.R.; Machius, M.; Rosen, M.K. Structural basis of Rho GTPase-mediated activation of the formin mDia1. Mol. Cell. 2005, 18, 273-2781.
216. Tang, D.D.; Gunst, S.J. The small GTPase Cdc42 regulates actin polymerization and tension development during contractile stimulation of smooth muscle. J. Biol. Chem. 2004, 279, 51722-51728.
217. Jin, L.; Ying, Z.; Webb, R.C. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am. J. Physiol Heart Circ. Physiol. 2004, 287, H1495-H1500.
218. Jernigan, N.L.; Walker, B.R.; Resta, T.C. Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295, L515-L529.
219. Mishra, N.; Nugent, W.H.; Mahavadi, S.; Walsh, S.W. Mechanisms of enhanced vascular reactivity in preeclampsia. Hypertension 2011, 58, 867-873.
220. Li, Q.F.; Tang, D.D. Role of p47(phox) in regulating Cdc42GAP, vimentin, and contraction in smooth muscle cells. Am. J. Physiol. Cell. Physiol. 2009, 297, C1424-C1433.
221. Li, Q.F.; Spinelli, A.M.; Tang, D.D. Cdc42GAP, reactive oxygen species, and the vimentin network. Am. J. Physiol. Cell. Physiol. 2009, 297, C299-C309.
222. Li, P.F.; Dietz, R.; von Harsdorf, R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 1997, 96, 3602-3609.
223. Rao, G.N.; Berk, B.C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 1992, 70, 593-599.
224. Deshpande, N.N.; Sorescu, D.; Seshiah, P.; Ushio-Fukai, M.; Akers, M.; Yin, Q.; Griendling, K.K. Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle. Antioxid. Redox Signal. 2002, 4, 845-854.
225. Li, J.; Li, W.; Su, J.; Liu, W.; Altura, B.T.; Altura, B.M. Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: Possible relation to neurodegenerative diseases and strokes. Brain Res. Bull. 2003, 62, 101-106.
226. Zafari, A.M.; Ushio-Fukai, M.; Akers, M.; Yin, Q.; Shah, A.; Harrison, D.G.; Taylor, W.R.; Griendling, K.K. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998, 32, 488-495.
227. Al Ghouleh, I.; Frazziano, G.; Rodriguez, A.I.; Csányi, G.; Maniar, S.; St Croix, C.M.; Kelley, E.E.; Egaña, L.A.; Song, G.J.; Bisello, A., et al. Aquaporin 1, Nox1, and Ask1 mediate oxidant-induced smooth muscle cell hypertrophy. Cardiovasc. Res. 2013, 97, 134-142.
228. Usui, T.; Okada, M.; Hara, Y.; Yamawaki, H. Death-associated protein kinase 3 mediates vascular inflammation and development of hypertension in spontaneously hypertensive rats. Hypertension 2012, 60, 1031-1039.
229. Wang, H.D.; Johns, D.G.; Xu, S.; Cohen, R.A. Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II. Am. J. Physiol. Heart Circ. Physiol. 2002, 282, H1697-H1702.
230. Zhang, Y.; Griendling, K.K.; Dikalova, A.; Owens, G.K.; Taylor, W.R. Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension 2005, 46, 732-737.
231. Matesanz, N.; Lafuente, N.; Azcutia, V.; Martín, D.; Cuadrado, A.; Nevado, J.; Rodríguez-Mañas, L.; Sánchez-Ferrer, C.F.; Peiró, C. Xanthine oxidase-derived extracellular superoxide anions stimulate activator protein 1 activity and hypertrophy in human vascular smooth muscle via c-Jun N-terminal kinase and p38 mitogen-activated protein kinases. J. Hypertens. 2007, 25, 609-618.
232. Taniyama, Y.; Ushio-Fukai, M.; Hitomi, H.; Rocic, P.; Kingsley, M.J.; Pfahnl, C.; Weber, D.S.; Alexander, R.W.; Griendling, K.K. Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2004, 287, C494-C499.
233. Ushio-Fukai, M.; Alexander, R.W.; Akers, M.; Griendling, K.K. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J. Biol. Chem. 1998, 273, 15022-15029.
234. Shi, M.; Yang, H.; Motley, E.D.; Guo, Z. Overexpression of Cu/Zn-superoxide dismutase and/or catalase in mice inhibits aorta smooth muscle cell proliferation. Am. J. Hypertens. 2004, 17, 450-456.
235. Wei, Y.; Whaley-Connell, A.T.; Chen, K.; Habibi, J.; Uptergrove, G.M.E.; Clark, S.E.; Stump, C.S.; Ferrario, C.M.; Sowers, J.R. NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat. Hypertension 2007, 50, 384-391.
236. Xiong, W.; Mactaggart, J.; Knispel, R.; Worth, J.; Zhu, Z.; Li, Y.; Sun, Y.; Baxter, B.T.; Johanning, J. Inhibition of reactive oxygen species attenuates aneurysm formation in a murine model. Atherosclerosis 2009, 202, 128-34.
237. Rizzoni, D.; Rodella, L.; Porteri, E.; Rezzani, R.; Guelfi, D.; Piccoli, A.; Castellano, M.; Muiesan, M.L.; Bianchi, R.; Rosei, E.A. Time course of apoptosis in small resistance arteries of spontaneously hypertensive rats. J. Hypertens. 2000, 18, 885-891.
238. Diep, Q.N.; Li, J.S.; Schiffrin, E.L. In vivo study of AT1 and AT2 angiotensin receptors in apoptosis in rat blood vessels. Hypertension 1999, 34, 617-624.
239. Irani, K. Oxidant signaling in vascular cell growth, death, and survival: A review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 2000, 87, 179-183.
240. Matsubara, H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ. Res. 1998, 83, 1182-1191.
241. Tao, J.; Zhang, Y.; Tuck, W.S.; Li, S. Urocortin II inhibits the apoptosis of mesenteric arterial smooth muscle cells via L-type calcium channels in spontaneously hypertensive rats. Cell. Physiol. Biochem. 2006, 17, 111-120.
242. Rodrigues, S.F.; Tran, E.D.; Fortes, Z.B.; Schmid-Schönbein, G.W. Matrix metalloproteinases cleave the β2-adrenergic receptor in spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 2010, 299, H25-H35.
243. Abdalvand, A.; Morton, J.S.; Bourque, S.L.; Quon, A.L.; Davidge, S.T. Matrix metalloproteinase enhances big-endothelin-1 constriction in mesenteric vessels of pregnant rats with reduced uterine blood flow. Hypertension 2013, 61, 488-493.
244. Van Lint, P.; Libert, C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J. Leukoc. Biol. 2007, 82, 1375-1381.
245. Márquez-Martín, A.; Jiménez-Altayó, F.; Dantas, A.P.; Caracuel, L.; Planas, A.M.; Vila, E. Middle cerebral artery alterations in a rat chronic hypoperfusion model. J. Appl. Physiol. 2012, 112, 511-518.
246. Spiers, J.P.; Kelso, E.J.; Siah, W.F.; Edge, G.; Song, G.; McDermott, B.J.; Hennessy, M. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: Effects of endothelin receptor blockade. J. Hypertens. 2005, 23, 1717-1724.
247. Marchesi, C.; Dentali, F.; Nicolini, E.; Maresca, A.M.; Tayebjee, M.H.; Franz, M.; Guasti, L.; Venco, A.; Schiffrin, E.L.; Lip, G.Y.H., et al. Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: A systematic review and meta-analysis. J. Hypertens. 2012, 30, 3-16.
248. Kadoglou, N.P.E.; Vrabas, I.S.; Sailer, N.; Kapelouzou, A.; Fotiadis, G.; Noussios, G.; Karayannacos, P.E.; Angelopoulou, N. Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes. Diabetes Metab. 2010, 36, 144-151.
249. Tayebjee, M.H.; Karalis, I.; Nadar, S.K.; Beevers, D.G.; MacFadyen, R.J.; Lip, G.Y.H. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and-2 levels in gestational hypertension. Am. J. Hypertens. 2005, 18, 325-329.
250. Fontana, V.; Silva, P.S.; Belo, V.A.; Antonio, R.C.; Ceron, C.S.; Biagi, C.; Gerlach, R.F.; Tanus-Santos, J.E. Consistent alterations of circulating matrix metalloproteinases levels in untreated hypertensives and in spontaneously hypertensive rats: A relevant pharmacological target. Basic Clin. Pharmacol. Toxicol. 2011, 109, 130-137.
251. Estrada-Gutierrez, G.; Cappello, R.E.; Mishra, N.; Romero, R.; Strauss, J.F., III; Walsh, S.W. Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: A critical mediator of vascular dysfunction. Am. J. Pathol. 2011, 178, 451-460.
252. Hu, T.; Luan, R.; Zhang, H.; Lau, W.B.; Wang, Q.; Zhang, Y.; Wang, H.C.; Tao, L. Hydrogen peroxide enhances osteopontin expression and matrix metalloproteinase activity in aortic vascular smooth muscle cells. Clin. Exp. Pharmacol. Physiol. 2009, 36, 626-630.
253. Nagareddy, P.R.; Chow, F.L.; Hao, L.; Wang, X.; Nishimura, T.; MacLeod, K.M.; McNeill, J.H.; Fernandez-Patron, C. Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesis. Cardiovasc. Res. 2009, 84, 368-377.
254. Kamioka, M.; Ishibashi, T.; Ohkawara, H.; Nagai, R.; Sugimoto, K.; Uekita, H.; Matsui, T.; Yamagishi, S.I.; Ando, K.; Sakamoto, T, et al. Involvement of membrane type 1-matrix metalloproteinase (MT1-MMP) in RAGE activation signaling pathways. J. Cell. Physiol. 2011, 226, 1554-1563.
255. Valentin, F.; Bueb, J.L.; Kieffer, P.; Tschirhart, E.; Atkinson, J. Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells. Fundam. Clin. Pharmacol. 2005, 19, 661-667.
256. Browatzki, M.; Larsen, D.; Pfeiffer, C.A. M.; Gehrke, S.G.; Schmidt, J.; Kranzhöfer, A.; Katus, H.A.; Kranzhöfer, R. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-κB and activator protein 1 in a redox-sensitive manner. J. Vasc. Res. 2005, 42, 415-423.
257. Luchtefeld, M.; Grote, K.; Grothusen, C.; Bley, S.; Bandlow, N.; Selle, T.; Struber, M.; Haverich, A.; Bavendiek, U.; Drexler, H., et al. Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem. Biophys. Res. Commun. 2005, 328, 183-188.
258. Zhang, H.S.; Wang, S.Q. Salvianolic acid B from Salvia miltiorrhiza inhibits tumor necrosis factor-α (TNF-α)-induced MMP-2 upregulation in human aortic smooth muscle cells via suppression of NAD(P)H oxidase-derived reactive oxygen species. J. Mol. Cell. Cardiol. 2006, 41, 138-148.
259. Castro, M.M.; Rizzi, E.; Ceron, C.S.; Guimaraes, D.A.; Rodrigues, G.J.; Bendhack, L.M.; Gerlach, R.F.; Tanus-Santos, J.E. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability. Nitric Oxide 2012, 26, 162-168.
260. Cau, S.B. A.; Guimaraes, D.A.; Rizzi, E.; Ceron, C.S.; Souza, L.L.; Tirapelli, C.R.; Gerlach, R.F.; Tanus-Santos, J.E. Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension. Br. J. Pharmacol. 2011, 164, 372-381.
261. Castro, M.M.; Rizzi, E.; Rodrigues, G.J.; Ceron, C.S.; Bendhack, L.M.; Gerlach, R.F; Tanus-Santos, J.E. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension. Free Radic. Biol. Med. 2009, 46, 1298-1307.
262. Feihl, F.; Liaudet, L.; Waeber, B.; Levy, B.I. Hypertension: A disease of the microcirculation? Hypertension 2006, 48, 1012-1017.
263. Vogt, C.J.; Schmid-Schönbein, G.W. Microvascular endothelial cell death and rarefaction in the glucocorticoid-induced hypertensive rat. Microcirculation 2001, 8, 129-139.
264. Gobé, G.; Browning, J.; Howard, T.; Hogg, N.; Winterford, C.; Cross, R. Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction. J. Struct. Biol. 1997, 118, 63-72.
265. Doughan, A.K.; Dikalov, S.I. Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis. Antioxid. Redox Signal. 2007, 9, 1825-1836.
266. Hao, C.N.; Geng, Y.J.; Li, F.; Yang, T.; Su, D.F.; Duan, J.L.; Li, Y. Insulin-like growth factor-1 receptor activation prevents hydrogen peroxide-induced oxidative stress, mitochondrial dysfunction and apoptosis. Apoptosis 2011, 16, 1118-1127.
267. Nako, H.; Kataoka, K.; Koibuchi, N.; Dong, Y.F.; Toyama, K.; Yamamoto, E.; Yasuda, O.; Ichijo, H.; Ogawa, H.; Kim-Mitsuyama, S. Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF. Hypertens. Res. 2012, 35, 194-200.
268. Kobayashi, N.; DeLano, F.A.; Schmid-Schönbein, G.W. Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 2114-2121.
269. Miller, S.J.; Norton, L.E.; Murphy, M.P.; Dalsing, M.C.; Unthank, J.L. The role of the renin-angiotensin system and oxidative stress in spontaneously hypertensive rat mesenteric collateral growth impairment. Am. J. Physiol. Heart Circ. Physiol. 2007, 292, H2523-H2531.
270. Khodo, S.N.; Dizin, E.; Sossauer, G.; Szanto, I.; Martin, P.Y.; Feraille, E.; Krause, K.H.; de Seigneux, S. NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury. J. Am. Soc. Nephrol. 2012, 23, 1967-1976.
271. Antonios, T.F.T.; Rattray, F.M.; Singer, D.R.J.; Markandu, N.D.; Mortimer, P.S.; MacGregor, G.A. Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart 2003, 89, 175-178.
272. Antonios, T.F.T.; Raghuraman, R.P.; D’Souza, R.; Nathan, P.; Wang, D.; Manyonda, I.T. Capillary remodeling in infants born to hypertensive pregnancy: Pilot study. Am. J. Hypertens. 2012, 25, 848-853.
273. Valcarcel-Ares, M.N.; Gautam, T.; Warrington, J.P.; Bailey-Downs, L.; Sosnowska, D.; de Cabo, R.; Losonczy, G.; Sonntag, W.E.; Ungvari, Z.; Csiszar, A. Disruption of Nrf2 signaling impairs angiogenic capacity of endothelial cells: Implications for microvascular aging. J. Gerontol. 2012, 67, 821-829.
274. Wagatsuma, A. Effect of aging on expression of angiogenesis-related factors in mouse skeletal muscle. Exp. Gerontol. 2006, 41, 49-54.
275. Kubo, M.; Li, T.S.; Kurazumi, H.; Takemoto, Y.; Ohshima, M.; Murata, T.; Katsura, S.; Morikage, N.; Furutani, A.; Hamano, K. Hypoxic preconditioning enhances angiogenic potential of bone marrow cells with aging-related functional impairment. Circ. J. 2012, 76, 986-994.
276. Swift, M.E.; Kleinman, H.K.; DiPietro, L.A. Impaired wound repair and delayed angiogenesis in aged mice. Lab. Investig. 1999, 79, 1479-1487.
277. Choudhery, M.S.; Khan, M.; Mahmood, R.; Mehmood, A.; Khan, S.N.; Riazuddin, S. Bone marrow derived mesenchymal stem cells from aged mice have reduced wound healing, angiogenesis, proliferation and anti-apoptosis capabilities. Cell. Biol. Int. 2012, 36, 747-753.
278. Jesmin, S.; Hattori, Y.; Togashi, H.; Ueno, K.I.; Yoshioka, M.; Sakuma, I. Age-related changes in cardiac expression of VEGF and its angiogenic receptor KDR in stroke-prone spontaneously hypertensive rats. Mol. Cell. Biochem. 2005, 272, 63-73.
279. Guzik, T.J.; Mussa, S.; Gastaldi, D.; Sadowski, J.; Ratnatunga, C.; Pillai, R.; Channon, K.M. Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002, 105, 1656-1662.
280. Bravard, A.; Bonnard, C.; Durand, A.; Chauvin, M.A.; Favier, R.; Vidal, H.; Rieusset, J. Inhibition of xanthine oxidase reduces hyperglycemia-induced oxidative stress and improves mitochondrial alterations in skeletal muscle of diabetic mice. Am. J. Physiol. Endocrinol. Metab. 2011, 300, E581-E591.
281. Rask-Madsen, C.; King, G.L., Mechanisms of disease: Endothelial dysfunction in insulin resistance and diabetes. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3, 46-56.
282. Tepper, O.M.; Galiano, R.D.; Capla, J.M.; Kalka, C.; Gagne, P.J.; Jacobowitz, G.R.; Levine, J.P.; Gurtner, G.C. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106, 2781-2786.
283. Aicher, A.; Heeschen, C.; Mildner-Rihm, C.; Urbich, C.; Ihling, C.; Technau-Ihling, K.; Zeiher, A.M.; Dimmeler, S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 2003, 9, 1370-1376.
284. Kowluru, R.A.; Chan, P.-S. Oxidative stress and diabetic retinopathy. Exp. Diabetes Res. 2007, 2007, doi:10.1155/2007/43603.
285. Lu, M.; Kuroki, M.; Amano, S.; Tolentino, M.; Keough, K.; Kim, I.; Bucala, R.; Adamis, A.P. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J. Clin. Investig. 1998, 101, 1219-1224.
286. Ushio-Fukai, M. Redox signaling in angiogenesis: Role of NADPH oxidase. Cardiovasc. Res. 2006, 71, 226-235.
287. Heerkens, E.H.; Shaw, L.; Ryding, A.; Brooker, G.; Mullins, J.J.; Austin, C.; Ohanian, V.; Heagerty, A.M. alphaV integrins are necessary for eutrophic inward remodeling of small arteries in hypertension. Hypertension 2006, 47, 281-287.
288. Hishikawa, K.; Oemar, B.S.; Yang, Z.; Luscher, T.F. Pulsatile stretch stimulates superoxide production and activates nuclear factor-kappa B in human coronary smooth muscle. Circ. Res. 1997, 81, 797-803.
289. Grote, K.; Flach, I.; Luchtefeld, M.; Akin, E.; Holland, S.M.; Drexler, H.; Schieffer, B. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ. Res. 2003, 92, e80-e86.
290. Leopold, J.A.; Loscalzo, J. Cyclic strain modulates resistance to oxidant stress by increasing G6PDH expression in smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2000, 279, H2477-H2485.
291. Lehoux, S. Redox signalling in vascular responses to shear and stretch. Cardiovasc. Res. 2006, 71, 269-279.
292. Lehoux, S.; Esposito, B.; Merval, R.; Loufrani, L.; Tedgui, A. Pulsatile stretch-induced extracellular signal-regulated kinase 1/2 activation in organ culture of rabbit aorta involves reactive oxygen species. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 2366-2372.
293. Ungvari, Z.; Csiszar, A.; Edwards, J.G.; Kaminski, P.M.; Wolin, M.S.; Kaley, G.; Koller, A. Increased superoxide production in coronary arteries in hyperhomocysteinemia: Role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 418-424.
294. Ungvari, Z.; Csiszar, A.; Huang, A.; Kaminski, P.M.; Wolin, M.S.; Koller, A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation 2003, 108, 1253-1258.
295. Oeckler, R.A.; Kaminski, P.M.; Wolin, M.S. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ. Res. 2003, 92, 23-31.
296. Ungvari, Z.; Csiszar, A.; Kaminski, P.M.; Wolin, M.S.; Koller, A. Chronic high pressure-induced arterial oxidative stress: Involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. Am. J. Pathol. 2004, 165, 219-226.
297. Lemarie, C.A.; Tharaux, P.L.; Esposito, B.; Tedgui, A.; Lehoux, S. Transforming growth factor-α mediates nuclear factor kappaB activation in strained arteries. Circ. Res. 2006, 99, 434-441.
298. Gebremedhin, D.; Terashvili, M.; Wickramasekera, N.; Zhang, D.X.; Rau, N.; Miura, H.; Harder, D.R. Redox signaling via oxidative inactivation of PTEN modulates pressure-dependent myogenic tone in rat middle cerebral arteries. PLoS One 2013, 8, e68498.
299. Schleifenbaum, J.; Kassmann, M.; Szijarto, I.A.; Hercule, H.C.; Tano, J.Y.; Weinert, S.; Heidenreich, M.; Pathan, A.R.; Anistan, Y.M.; Alenina, N., et al. Stretch-activation of angiotensin II type 1a receptors contributes to the myogenic response of mouse mesenteric and renal arteries. Circ. Res. 2014, 115, 263-272.
300. Staiculescu, M.C.; Ramirez-Perez, F.I.; Castorena-Gonzalez, J.A.; Hong, Z.; Sun, Z.; Meininger, G.A.; Martinez-Lemus, L.A. Lysophosphatidic acid induces integrin activation in vascular smooth muscle and alters arteriolar myogenic vasoconstriction. Front. Physiol. 2014, 5, 413, doi:10.3389/fphys.2014.00413.
301. Martinez-Lemus, L.A.; Crow, T.; Davis, M.J.; Meininger, G.A. αvβ3-and α5β1-integrin blockade inhibits myogenic constriction of skeletal muscle resistance arterioles. Am. J. Physiol. Heart Circ. Physiol. 2005, 289, H322-H329.